These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26349157)

  • 1. [Endophthalmitis as a complication of intravitreal anti-VEGF therapy in patients with exudative age-related macular degeneration and degenerative myopia].
    Kuhicka-Trząska A; Jędrychowska-Jamhorska JJ; Kulig-Stochmal A; Morawski K; Romanowska-Dixon B
    Klin Oczna; 2015; 117(1):35-9. PubMed ID: 26349157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
    Chaudhary KM; Romero JM; Ezon I; Fastenberg DM; Deramo VA
    Retina; 2013; 33(7):1407-16. PubMed ID: 23492945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.
    Yamashiro K; Tsujikawa A; Miyamoto K; Oh H; Otani A; Tamuara H; Ooto S; Sasahara M; Iwama D; Yoshimura N
    Retina; 2010 Mar; 30(3):485-90. PubMed ID: 19952993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.
    Moshfeghi AA
    Semin Ophthalmol; 2011 May; 26(3):139-48. PubMed ID: 21609227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endophthalmitis as a serious complication of intravitreal drug delivery].
    Lommatzsch AP; Bartels S; Heimes B; Spital G; Dietzel M; Freistühler M; Bornfeld N; Pauleikhoff D
    Klin Monbl Augenheilkd; 2013 Nov; 230(11):1130-4. PubMed ID: 24065511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection.
    Artunay O; Yuzbasioglu E; Rasier R; Sengül A; Bahcecioglu H
    Eye (Lond); 2009 Dec; 23(12):2187-93. PubMed ID: 19218994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of subspecialty ophthalmic care: endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor medications.
    Haddock LJ; Ramsey DJ; Young LH
    Semin Ophthalmol; 2014; 29(5-6):257-62. PubMed ID: 25325851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.
    Matthews JL; Dubovy SR; Goldberg RA; Flynn HW
    Ophthalmology; 2014 Mar; 121(3):702-8. PubMed ID: 24439760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
    Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
    Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration.
    Wickremasinghe SS; Michalova K; Gilhotra J; Guymer RH; Harper CA; Wong TY; Qureshi S
    Ophthalmology; 2008 Nov; 115(11):1911-5. PubMed ID: 18672291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of post-intravitreal anti-VEGF endophthalmitis at Thammasat University Hospital.
    Kanchanaranya N; Rojdamrongratana D; Piyasoonthorn P
    J Med Assoc Thai; 2015 May; 98(5):489-94. PubMed ID: 26058278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of vitrectomy in endophthalmitis : How immediate vitrectomy can restore visual acuity].
    Damm LJ; Boden KT; Januschowski K
    Ophthalmologe; 2019 Jun; 116(6):569-571. PubMed ID: 30076431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.
    Chan WM; Lai TY; Chan KP; Li H; Liu DT; Lam DS; Pang CP
    Retina; 2008 Oct; 28(9):1308-13. PubMed ID: 18728623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual results following intravitreal Bevacizumab in neovascular age-related macular degeneration.
    Iqbal K; Baig J; Jamil AZ; Jamil H; Mirza K; Khan T
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):535-8. PubMed ID: 21914409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab treatment for exudative age-related macular degeneration with good visual acuity.
    Axer-Siegel R; Bor E; Bourla DH; Weinberger D; Mimouni K
    Retina; 2012 Oct; 32(9):1811-20. PubMed ID: 22825407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.
    Spaide RF; Laud K; Fine HF; Klancnik JM; Meyerle CB; Yannuzzi LA; Sorenson J; Slakter J; Fisher YL; Cooney MJ
    Retina; 2006 Apr; 26(4):383-90. PubMed ID: 16603955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal injection of anti-VEGF and diagnosis of primary intraocular central nervous system lymphoma.
    Gambrelle J; Missotten G; Delhoum S; Desjardins L
    J Fr Ophtalmol; 2013 May; 36(5):431-4. PubMed ID: 23306179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.